Cellectis S.A.
Cellectis S.A. (CLLS) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
clls · stock forecast · 17 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 17 Wall Street analysts in the past 3 months
Buy
17 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$9.00
Consensus
$9.00
+207.2% upside
Low
$9.00
Median: $9 · Last Close: $2.93
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $2.78 | ↓ 5.00% |
1-day model range: $2.77–$2.8. Peak: $2.8 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $1 | -50.0% |
| 2028 | $1 | -62.5% |
| 2029 | $1 | -67.2% |
| 2030 | $1 | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CLLS · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-14 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2025-10-17 | Barclays | Maintains | Overweight→Overweight |
| 2025-05-13 | Barclays | Maintains | Overweight→Overweight |
| 2024-11-05 | Barclays | Maintains | Overweight→Overweight |
| 2024-06-12 | Oppenheimer | Maintains | Outperform→Outperform |
| 2024-05-31 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2023-11-01 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2023-08-08 | Oppenheimer | Maintains | Outperform→Outperform |
| 2023-08-07 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2023-04-05 | Citigroup | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Cellectis S.A. (CLLS) stock. Of the recent 40 rating actions, 3 were upgrades and 5 were downgrades. 17 analysts currently cover CLLS.
Analyst Recommendation Trends
CLLS analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$61M
↓ 16.7% YoY
Revenue Next Year
$118M
↑ 93.2% YoY
EPS This Year
$-0.92
EPS Next Year
$-0.74
↓ 19.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast CLLS EPS of $-0.92 for the current fiscal year, based on estimates from 6 analysts. The CLLS revenue forecast is $61M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CLLS stock forecast is supported by two independent data sources: analyst consensus ratings from 17 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CLLS price target is $9.00 (+207.2% upside), with an analyst consensus of Buy.
The CLLS short-term stock prediction for tomorrow is $2.78 (-5.00%). The CLLS stock price prediction for 2027 estimates an average of $1. The CLLS stock prediction for 2030 projects a range of $1–$1.
Cellectis S.A. trades on NASDAQ under the ticker CLLS. The CLLS stock outlook for 2027 is broadly positive, supported by a Buy consensus among 82% of covering analysts.
Frequently asked questions
CLLS forecast · 8 questionsAccording to 17 Wall Street analysts, the average 12-month CLLS price target is $9.00, with a high forecast of $9.00 and a low of $9.00. The median price target is shown in the chart above when available. This implies +207.2% potential upside from the current price of $2.93.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.